Weight-loss jabs may have to be used for many years if the long-term benefits to patients and health care systems are to be realised, experts have said.The drugs are sold under brand names like ...

Excessive weight has been a persistent problem in America, where at least one in five adults in each U.S. state is living ...

STARING at yet another pregnancy test, Erica Coronado was thrilled but terrified. The 36-year-old had given up hope of a baby after two years of trying and the agony of a stillbirth. So seeing two ...

HANNAH Metcalfe caught a whiff of something very unpleasant and felt her cheeks flush red. “It’s him, he’s farted!” she squealed, pointing at one of the burly blokes ...

Hims & Hers Health is betting that the cash-pay market for weight-loss drugs will drive up customer demand although some ...

CHICAGO -- Physicians debated the idea of the American Medical Association (AMA) supporting a registry to track adverse ...

The U.S.-listed shares of Danish drugmaker Novo Nordisk rose Tuesday following a report that an activist investor is building ...

Using a medication outside of its prescribed method is always risky — and in this case, especially unnecessary,” Dr. Michael Snyder told The Post.

GLP-1 medications offer promising benefits for obesity and diabetes patients, with studies showing reduced heart attack risk ...

GoodRx says that with the support of a healthcare team, a clear transition plan, and a few cost-saving tools, you can make ...

Omada Health closed 21% higher in its Nasdaq debut after raising $150 million. Backed by strong growth and GLP-1 momentum, ...